How do I find a HER2-Low Breast Cancer specialist vs a general oncologist

Finding a HER2-Low Breast Cancer Specialist

This is an excellent question, especially since HER2-low breast cancer is a relatively newer classification that opened treatment doors just a few years ago. Let me walk you through how to find the right specialist for your care.

Understanding Why Specialist Knowledge Matters for HER2-Low

According to the CancerPatientLab webinar on proteomics, HER2-low breast cancer represents a significant population—roughly 80% of breast cancer patients fall into the HER2 0, 1+, or 2+ categories (compared to only 15-20% with HER2 3+). This means many general oncologists may have limited experience with HER2-low specific treatments, particularly newer options like trastuzumab deruxtecan (Enhertu), which was FDA-approved specifically for HER2-low patients and showed a 24-month overall survival compared to 17 months with chemotherapy alone.

How to Find a HER2-Low Specialist

1. Start with Major Cancer Centers

Look for National Comprehensive Cancer Network (NCCN)-designated comprehensive cancer centers or academic medical centers, which typically have:

• Breast cancer tumor boards (multidisciplinary teams that review complex cases)
• Oncologists who specialize specifically in HER2-targeted therapies
• Access to newer treatment protocols and clinical trials
• Pathologists experienced in precise HER2 measurement

2. Ask Specific Questions When Interviewing Oncologists

According to Dr. [removed] Lopez-Correa (an MD/PhD who navigated her own breast cancer), you should:

• Ask about their experience with HER2-low patients specifically — not just HER2-positive
• Inquire about proteomic or advanced testing — Ask: "Do you order HER2 protein level testing beyond standard immunohistochemistry (IHC)?" This matters because standard IHC may show 1+ or 2+, but protein-level testing can reveal actionable HER2 expression
• Ask about Enhertu and other HER2-low targeted therapies — A specialist will be familiar with this drug and when it's appropriate
• Request their familiarity with precision medicine approaches — Ask: "How do you use molecular profiling to guide treatment decisions?"

3. Look for These Credentials/Affiliations

• Medical Oncologists with breast cancer subspecialty (often listed as "breast medical oncologist")
• Tumor board participation — Ask if they present cases at multidisciplinary tumor boards
• ASCO (American Society of Clinical Oncology) membership — ASCO maintains updated guidelines on HER2-low treatment
• Participation in clinical trials — Specialists often lead or participate in trials for newer HER2-low therapies

4. Verify Their Knowledge of Current Guidelines

According to the available medical literature, ask your potential oncologist:

• "Are you familiar with the NCCN guidelines for HER2-low breast cancer?"
• "What is your standard approach for patients with HER2 1+ or 2+ tumors?"
• "Do you offer or discuss Enhertu for HER2-low patients?"

A specialist will reference current guidelines and explain how they apply to YOUR specific situation.

Red Flags vs. Green Flags

🚩 Red Flags:

• Oncologist says "HER2-low doesn't matter" or "we treat it like triple-negative"
• They're unfamiliar with Enhertu or trastuzumab deruxtecan
• They don't discuss your specific HER2 protein levels
• They seem resistant to precision medicine approaches

✅ Green Flags:

• They ask detailed questions about your HER2 testing methodology
• They discuss multiple treatment options specific to HER2-low
• They mention clinical trials or newer therapies
• They collaborate with pathologists on biomarker interpretation
• They're willing to discuss off-label or emerging treatments

Getting the Right Testing First

Before you even need a specialist, ensure you have:

• Precise HER2 measurement — Standard IHC (immunohistochemistry) may not capture the full picture. Ask if your pathology report includes actual HER2 protein levels, not just the 0-3+ score
• Hormone receptor status (ER/PR) — Important for treatment planning
• Ki-67 testing — Measures tumor growth rate
• Consider genomic testing — Tests like Oncotype DX can help guide chemotherapy decisions

According to Dr. [removed]-Correa's guidance, you should "push for comprehensive genomic analysis" and "request detailed reports" from your pathology team.

How to Access Specialists

1. Ask your current oncologist for a referral to a breast cancer specialist or HER2-low expert
2. Contact major cancer centers directly — Many have patient navigation services to help match you with appropriate specialists
3. Use NCCN's "Find an NCCN Member Institution" tool on their website
4. Call your insurance to verify in-network specialists with breast cancer expertise
5. Join breast cancer communities — Organizations like the American Cancer Society can connect you with patient advocates who've found good specialists

Key Questions to Ask During Your First Consultation

1. "How many HER2-low breast cancer patients have you treated?"
2. "What is your approach to treatment for my specific HER2 status and hormone receptor status?"
3. "Would you recommend Enhertu or other HER2-targeted therapies for my case?"
4. "Do you have access to clinical trials for HER2-low patients?"
5. "How do you stay current with emerging HER2-low treatment options?"

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.